Trauma drama: researches investigate 'drama queen' of immune system

August 8, 2011 in Medical research

Kansas State University's Sherry Fleming is investigating the factor that initiates the immune system's "drama queen": the one responsible for intestinal cell damage after hemorrhage.

Fleming, an associate professor in the Division of Biology, is using a $140,000 grant from the to identify the molecule responsible for the that can cause cell death in the intestines after trauma.

"What's starting this drama queen situation? A 13-year-old girl doesn't usually become a drama queen without a reason. There's something that initiated the drama -- clothes, shoes, make-up, movies, etc.," Fleming said. "With hemorrhage, we're looking for the initiating factor in the drama which occurs after trauma."

After a traumatic event, such as the loss of a limb or severe bleeding, the body cuts off blood flow to the intestines, sending more blood to the like the heart, lungs and brain, Fleming said. During that time, cells in the gut release molecular markers to let the body know that they are not getting oxygen.

After the trauma is resolved, blood flow is returned to the gut and a protein in the blood -- known as beta2 1 in mice and apolipoprotein H in humans -- binds to the on the cell to notify antibodies that there is a problem. The antibodies then activate a cascade of proteins, known as complement, that normally help the immune system by killing bacteria and helping rid tissues of . However, after a trauma this system can overreact and unnecessarily kill healthy cells.

"If you've been in a car accident and sever an arm or start hemorrhaging, you want complement there to protect you from bacteria. So we don't want to stop all complement action entirely," Fleming said.

But Fleming is looking for a way to interrupt the chain of events leading to the over activation of complement following a traumatic event, because often develop further complications throughout their body due to the activation of complement, she said.

"Many times trauma patients who have lost a lot of blood will end up with acute respiratory distress syndrome or multiple organ dysfunction syndrome, due to the complement system overreacting," Fleming said. "So they not only have to deal with the trauma, but also with their immune system attacking things that it shouldn't."

As a possible solution, Fleming and her lab group have developed a peptide that takes the place of the beta2 protein in binding to the molecular marker on the cell's surface, thus preventing the activation of complement.

"This treatment is a promising solution," Fleming said. "The funding from the American Heart Association will give us the opportunity to make major progress in this research."

Provided by Kansas State University search and more info website

not rated yet  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

knowledge_treehouse
Aug 09, 2011

Rank: not rated yet
This article didn't make it clear to me whether complements result from molecular markers binding to cells in the areas blood was re-routed from to ensure that vital organs were not deprived of blood during blood loss or in the area around the bleeding wound.
Rank not rated yet
Relevant PhysicsForums posts

More news stories

H. pylori, smoking trends, and gastric cancer in US men

Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...

Medical research created 10 hours ago | popularity not rated yet | comments 0

Common food supplement fights degenerative brain disorders

Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...

Medical research created 15 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast

Finding a family for a pair of orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...

Medical research created 15 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Medical research created 16 hours ago | popularity 4.6 / 5 (7) | comments 0 | with audio podcast

Do men's and women's hearts burn fuel differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...

Medical research created 19 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.